Abstract:Ubiquitin-like modifier-activating enzyme 7 (UBA7) is a specific E1-like ubiquitin-activating enzyme involved in interferon-stimulated gene 15 (ISG15) conjugation. UBA7 expression has been reported to be notably decreased in lung cancer. The present study aimed to investigate the changes in UBA7 expression in breast cancer and the association between UBA7 expression and clinical characteristics, and to elucidate the diagnostic and prognostic significance of UBA7 in breast cancer. The clinical data and RNA-sequencing expression values of 1,104 patients with breast cancer were downloaded from The Cancer Genome Atlas database. The associations between UBA7 expression and clinical characteristics were determined using chi(2) and Fisher's exact tests. UBA7 expression values were divided into low and high groups using the optimal cut-off value, as determined by the overall survival (OS) value identified via a receiver operating characteristic (ROC) curve analysis, to further study the association between UBA7 expression and clinical characteristics. The diagnostic capability of UBA7 was assessed via ROC analysis, and Kaplan-Meier curve and Cox regression analyses were performed to determine the prognostic value of UBA7. The results demonstrated that UBA7 expression was decreased in breast cancer, and significant differences were observed between groups with regards to vital status, tumor classification, metastasis classification, histological type, sex, molecular subtype, and expression levels of progesterone receptor, estrogen receptor (ER) and human epidermal growth factor receptor 2. Low and high UBA7 expression levels were associated with age, ER expression, menopause status, Tumor-Node-Metastasis classification stage, margin status, vital status, radiation therapy use, OS and relapse-free survival. Furthermore, patients with low UBA7 expression levels had a poor prognosis. UBA7 expression also demonstrated an ability to diagnose patients at all clinical stages. Taken together, the results indicated that UBA7 expression was significantly decreased in breast cancer, and was associated with clinical characteristics and prognosis. Thus, UBA7 can be deemed as a potential biomarker in breast cancer, and may serve as a target in treatment.

Expression and Significance of UbcH10 in Breast Cancer

Expression of UbcH1O in early cervical cancer and its clinical significance

The Analysis of the Anti-Tumor Mechanism of Ursolic Acid Using Connectively Map Approach in Breast Cancer Cells Line MCF-7

Ubiquitin-like modifier-activating enzyme 7 as a marker for the diagnosis and prognosis of breast cancer

High Expression of UNC5B Enhances Tumor Proliferation, Increases Metastasis, and Worsens Prognosis in Breast Cancer.

[Ubch10 Expression in Hepatocellular Carcinoma and Its Clinicopathological Significance].

Functional Expression of B7H1 on Pancreatic Carcinoma Panc-1 Cells

Expression of UbcH10 in Pancreatic Ductal Adenocarcinoma and Its Correlation with Prognosis

UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer

Anti-cancer Mechanism of Survivin Sirna Plasmid Mu6/survivin

LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway

Effect of ubiquitin like with PHD and ring finger domains 1 on biological behaviors of SGC-7901 cells

Insights into Immune Infiltration and Functional Implications

The Clinicopathological Significance of ZNF10 in Invasive Ductal Carcinoma of the Breast

KIAA0101 and UbcH10 interact to regulate non-small cell lung cancer cell proliferation by disrupting the function of the spindle assembly checkpoint

The Prognostic Significance of Cdc6 and Cdt1 in Breast Cancer

Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune response

MiR-886-5p inhibition inhibits growth and induces apoptosis of MCF7 cells.

Analysis of miR-34a Expression and Funcition in Breast Cancer Tissues and Cells

Effects of siRNA against survivin combined with tamoxifen on the proliferation and apoptosis in breast cancer MCF-7 cell

Over-expression of Ubiquitin Carboxy Terminal Hydrolase-L1 Induces Apoptosis in Breast Cancer Cells.